Results 251 to 260 of about 3,389,488 (311)

A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain.

, 1988
Molly Browne, J.E. Carey, C.G. Chapman, A. W. R. TYRRELL, Claire Entwisle, G. M. Lawrence, B. Reavy, Ian B. Dodd, A.F. Esmail, J.H. Robinson   +9 more
openalex   +1 more source

Serum Soluble Urokinase-Type Plasminogen Activator Receptor: A Promising Biomarker for Stable Chronic Obstructive Pulmonary Disease Patients. [PDF]

Cureus
D R, Johnson P, Das S, Gr S.
europepmc   +1 more source

Interplay of integrins and selectins in metastasis

Molecular Oncology, Volume 19, Issue 6, Page 1582-1611, June 2025.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

, 1989
Paolo Golino, J H Ashton, J McNatt, Pia Glas-Greenwalt, S K Yao, R A O'Brien, L. Maximilian Buja, J. T. Willerson   +7 more
openalex   +1 more source

The Role of the Plasminogen Activator Inhibitor 1 ( PAI1 ) in Ovarian Cancer: Mechanisms and Therapeutic Implications. [PDF]

Glob Med Genet
Mathews SG, Krishna RBD, M L, K N, Murali S, Agarwal P, Rani E, F AM.   +7 more
europepmc   +1 more source

Protein Kinase C and the Stimulation of Tissue Plasminogen Activator Release from Human Endothelial Cells

, 1989
E G Levin, K.R. Marotti, Lydia Santell
openalex   +1 more source

Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors. [PDF]

Ther Adv Respir Dis
Sedhai YR, Bhat P, Acharya R, Qureshi NQ, Mohammed F, Waheed I, Khan TMA, Ahmed MA, Kazimuddin N, Kafle A, Steff RT, Singh K.   +11 more
europepmc   +1 more source

Hydrophobin‐Coated Echogenic Microbubbles for Molecular Targeting of Tumor Cells

Advanced Science, Volume 12, Issue 22, June 12, 2025.
Echogenic microbubbles based on hydrophobin and corresponding fusion protein (HFBI‐domZ) are developed as contrast agents for cancer diagnostics. Hydrophobin provides high stabilization of encapsulated perfluoro‐n‐butane, and fusion proteins allow further versatile functionalization with antibodies. In‐vitro experiments indicate that these microbubbles
Hedar H. Al‐Terke, Grégory Beaune, Muhammad Junaid, Jani Seitsonen, Arja Paananen, Pierangelo Metrangolo, Jaakko V. I. Timonen, Jussi Joensuu, Robin H. A. Ras   +8 more
wiley   +1 more source

Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.

, 1984
Christa Heussen, F Joubert, Eugene B. Dowdle   +2 more
openalex   +1 more source

Can Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Be Used to Treat Persistent Hemothorax After Robotic Lobectomy? [PDF]

Cureus
Vivekanandan DD, Louis M, Canaan LN, Gersch K.   +3 more
europepmc   +1 more source